115 related articles for article (PubMed ID: 22245236)
41. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients.
Jadid FZ; Chihab H; Alj HS; Elfihry R; Zaidane I; Tazi S; Badre W; Marchio A; El Filali KM; Tahiri M; Saile R; Pineau P; Ezzikouri S; Benjelloun S
Infect Genet Evol; 2018 Dec; 66():1-8. PubMed ID: 30172885
[TBL] [Abstract][Full Text] [Related]
42. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.
Kato N; Ji G; Wang Y; Baba M; Hoshida Y; Otsuka M; Taniguchi H; Moriyama M; Dharel N; Goto T; Shao RX; Matsuura T; Ishii K; Shiina S; Kawabe T; Muramatsu M; Omata M
Hepatology; 2005 Oct; 42(4):846-53. PubMed ID: 16175604
[TBL] [Abstract][Full Text] [Related]
43. Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin.
Jabłonowska E; Piekarska A; Koślińska-Berkan E; Omulecka A; Szymańska B; Wójcik K
Acta Biochim Pol; 2012; 59(3):333-7. PubMed ID: 22924160
[TBL] [Abstract][Full Text] [Related]
44. Study of Interleukin 28B rs12979860 and rs8099917 Polymorphisms and T-helper 1 Response in Hepatitis C Virus Patients.
Ea R; Aa G; Ag ES; Ma A
Egypt J Immunol; 2015 Jun; 22(2):57-68. PubMed ID: 28502145
[TBL] [Abstract][Full Text] [Related]
45. Impact of a single nucleotide polymorphism upstream of the IL28B gene in patients positive for anti-HCV antibody in an HCV hyperendemic area in Japan.
Oda K; Uto H; Kumagai K; Ido A; Kusumoto K; Shimoda K; Hayashi K; Stuver SO; Tanaka Y; Nishida N; Tokunaga K; Tsubouchi H
J Med Virol; 2014 Nov; 86(11):1877-85. PubMed ID: 25100136
[TBL] [Abstract][Full Text] [Related]
46. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.
Aziz H; Raza A; Ali K; Khattak JZ; Irfan J; Gill ML
Int J Infect Dis; 2015 Jan; 30():91-7. PubMed ID: 25462177
[TBL] [Abstract][Full Text] [Related]
47. Relationship between IL28B gene rs8099917 polymorphism and SVR in Turkish patients with hepatitis C virus genotype 1.
Akkız H; Akgöllü E; Bekar A; Yıldırım S; Sandıkçı M; Ülger Y; Yalınbaş Kaya B; Kuran S; Üsküdar O
Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):711-7. PubMed ID: 25857516
[TBL] [Abstract][Full Text] [Related]
48. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients.
Elsayed HM; Nabiel Y; Sheta T
Immunol Invest; 2017 Feb; 46(2):123-133. PubMed ID: 27819525
[TBL] [Abstract][Full Text] [Related]
49. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
50. Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: a case control study.
Tomoda T; Nouso K; Sakai A; Ouchida M; Kobayashi S; Miyahara K; Onishi H; Nakamura S; Yamamoto K; Shimizu K
J Gastroenterol Hepatol; 2012 Apr; 27(4):797-804. PubMed ID: 22004425
[TBL] [Abstract][Full Text] [Related]
51. Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs.
Cusato J; Boglione L; De Nicolò A; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Cantù M; Carcieri C; Cariti G; Di Perri G; D'Avolio A
Cancer Chemother Pharmacol; 2018 Mar; 81(3):615-620. PubMed ID: 29356898
[TBL] [Abstract][Full Text] [Related]
52. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.
Rauch A; Kutalik Z; Descombes P; Cai T; Di Iulio J; Mueller T; Bochud M; Battegay M; Bernasconi E; Borovicka J; Colombo S; Cerny A; Dufour JF; Furrer H; Günthard HF; Heim M; Hirschel B; Malinverni R; Moradpour D; Müllhaupt B; Witteck A; Beckmann JS; Berg T; Bergmann S; Negro F; Telenti A; Bochud PY; ;
Gastroenterology; 2010 Apr; 138(4):1338-45, 1345.e1-7. PubMed ID: 20060832
[TBL] [Abstract][Full Text] [Related]
53. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
[TBL] [Abstract][Full Text] [Related]
54. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.
ELBassuoni MA; Abd El Fatah G; Zaghla H
Immunol Lett; 2015 Dec; 168(2):240-5. PubMed ID: 26367076
[TBL] [Abstract][Full Text] [Related]
55. Role of IFN-ks, IFN-ks related genes and the DEPDC5 gene in Hepatitis B virus-related liver disease.
Ma N; Zhang X; Yu F; Gao P; Fan Q; Liu L; Liu D
J Viral Hepat; 2014 Jul; 21(7):e29-38. PubMed ID: 25032264
[TBL] [Abstract][Full Text] [Related]
56. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y
Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823
[TBL] [Abstract][Full Text] [Related]
57. IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C.
Bochud PY; Bibert S; Negro F; Haagmans B; Soulier A; Ferrari C; Missale G; Zeuzem S; Pawlotsky JM; Schalm S; Hellstrand K; Neumann AU; Lagging M
J Hepatol; 2011 Nov; 55(5):980-8. PubMed ID: 21354446
[TBL] [Abstract][Full Text] [Related]
58. An intronic single nucleotide polymorphism in the MUTYH gene is associated with increased risk for HCV-induced hepatocellular carcinoma.
Sakurada A; Miyanishi K; Tanaka S; Sato M; Sakamoto H; Kawano Y; Takada K; Nakabeppu Y; Kobune M; Kato J
Free Radic Biol Med; 2018 Dec; 129():88-96. PubMed ID: 30218772
[TBL] [Abstract][Full Text] [Related]
59. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
[TBL] [Abstract][Full Text] [Related]
60. Role of
Barooah P; Saikia S; Bharadwaj R; Sarmah P; Bhattacharyya M; Goswami B; Medhi S
Genet Test Mol Biomarkers; 2019 May; 23(5):325-331. PubMed ID: 30942619
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
